Karlinska et al. documented a median CRP level of 21 mg/L (IQR 4–76) in stroke patients with cancer, which is considerably higher than the median CRP level of 3.5 mg/L (IQR 1.5–9) found in our study. This evidence concerns the gene CRP and cancer.